Midterm results after arterial switch operation for transposition of the great arteries: a single centre experience

  • Aron Frederik Popov1, 4Email author,

    Affiliated with

    • Theodor Tirilomis1Email author,

      Affiliated with

      • Michael Giesler1,

        Affiliated with

        • Kasim Oguz Coskun1,

          Affiliated with

          • Jose Hinz2,

            Affiliated with

            • Gerd Gunnar Hanekop2,

              Affiliated with

              • Verena Gravenhorst3,

                Affiliated with

                • Thomas Paul3 and

                  Affiliated with

                  • Wolfgang Ruschewski1

                    Affiliated with

                    Journal of Cardiothoracic Surgery20127:83

                    DOI: 10.1186/1749-8090-7-83

                    Received: 12 August 2012

                    Accepted: 2 September 2012

                    Published: 7 September 2012

                    Abstract

                    Background

                    The arterial switch operation (ASO) has become the surgical approach of choice for d-transposition of the great arteries (d-TGA). There is, however an increased incidence of midterm and longterm adverse sequelae in some survivors. In order to evaluate operative risk and midterm outcome in this population, we reviewed patients who underwent ASO for TGA at our centre.

                    Methods

                    In this retrospective study 52 consecutive patients with TGA who underwent ASO between 04/1991 and 12/1999 were included. To analyze the predictors for mortality and adverse events (coronary stenoses, distortion of the pulmonary arteries, dilatation of the neoaortic root, and aortic regurgitation), a multivariate analysis was performed. The follow-up time was ranged from 1–10 years (mean 5 years, cumulative 260 patient-years).

                    Results

                    All over mortality rate was 15.4% and was only observed in the early postoperative period till 1994. The predictors for poor operative survival were low APGAR-score, older age at surgery, and necessity of associated surgical procedures. Late re-operations were necessary in 6 patients (13.6%) and included a pulmonary artery patch enlargement due to supravalvular stenosis (n = 3), coronary revascularisation due to coronary stenosis in a coronary anatomy type E, aortic valve replacement due to neoaortic valve regurgitation (n = 2), and patch-plasty of a pulmonary vein due to obstruction (n = 1). The dilatation of neoaortic root was not observed in the follow up.

                    Conclusions

                    ASO remains the procedure of choice for TGA with acceptable early and late outcome in terms of overall survival and freedom of reoperation. Although ASO is often complex and may be associated with morbidity, most patients survived without major complications even in a small centre.

                    Keywords

                    Arterial switch operation Transposition of great arteries Midterm outcome

                    Background

                    Since the introduction of the arterial switch operation (ASO) by Jatene et al. in 1975 [1], the procedure has become the surgical treatment of choice for the anatomical repair of the transposition of the great arteries (TGA). A limited number of long-term studies revealed an excellent survival and freedom from re-operation in patients undergoing ASO [26]. However, one of the major concerns about the ASO is the possible deterioration of neoaortic valve function with a dilatation of neoaortic root [7] and the stenoses of coronary arteries which appear occasionally and needs surgical intervention [2]. The purpose of the present study was to review our results of ASO for TGA and to evaluate early and midterm survival rates, morbidity, and complications in a single centre cohort retrospectively followed up for as long 10 years. Moreover, risk factors for mortality and adverse midterm events after ASO for TGA (coronary stenoses, distortion of the pulmonary arteries, dilatation of the neoaortic root, and aortic valve regurgitation) were the endpoints of interest.

                    Methods

                    Study population

                    The retrospective single centre study was approved by the ethics committee of the Medical Faculty, University of Göttingen. Between April 1991 and December 1999, 52 consecutive patients (median age 10 ± 49 days, range 2–338 days) underwent an ASO at the University of Göttingen.

                    Data collection

                    All perioperative data was collected retrospectively with the help of medical records, echocardiographic and cardiac catheterization data as well operative notes. The clinical follow-up included an examination by the referring pediatric cardiologist at regular intervals or in our institution by the pediatric cardiologist. The echocardiographic data for the study was taken from the cardiologists’ report. The midterm follow-up was obtained by review of patient records and clinic notes.

                    Patients’ characteristics

                    For 52 patients, including 37 males and 15 females, the median age at time of surgery was 10 ± 49.61 days (range, 2–338 days). The initial diagnosis was a simple TGA in 34 (66%) patients, TGA with a ventricular septal defect (VSD) in 10 (19%) patients, Taussig-Bing in 2 (4%) patients, TGA with coarctation of the aorta (CoA) in 2 (4%) patients, and TGA with CoA and VSD in 4 (8%) patients. 42 patients received Rashkind’s balloon atrial septostomy and the duration between septostomy to surgery was 7 ± 42.45 days (range, 1–271 days).

                    Standard surgical techniques were used. The following details were considered. A single initial infusion of crystalloid (Brettschneider solution) cardioplegia was used for the majority of the series with a dose of 30 ml/kg over 7 minutes. In five cases a total circulatory arrest with deep hypothermia (18°C) was necessary for CoA repair.

                    Prior to ASO, 8 patients had cardiac surgical procedures which were Blalock-Hanlon Operation (n = 3), pulmonary artery banding (n = 2), CoA correction (n = 2), and CoA correction with a an aortic arch obstruction repair (n = 1). We had 3 preterm births. One was with 31 completed weeks and with bronchopulmonary dysplasia. The second was with 35 completed weeks, and the remaining one had 36 completed weeks and had a respiratory distress syndrome and a diabetic fetopathy

                    A total of 34 patients (66%) were mechanically ventilated and 3 patients had a complication (intracranial hemorrhage, renal dysfunction, chest infection) before ASO. On echocardiographic examination a mean diameters of the aorta and the pulmonary artery were 11 ± 1.56 mm (range, 8-15 mm) and 12 ± 1.84 mm (range, 10-17 mm) respectively. Preoperative catheterization was performed in all patients and coronary pattern was identified with aortography or coronary angiography. It was in the beginning a standard protocol. Currently, we changed that protocol. Not every patient received a catheterization preoperative nowadays. Moreover, it was also a part of the protocol in our department to leave the chest open some cases to aid in hemodynamic and respiratory stability in the initial postoperative period.

                    In accordance with the Yacoub’s coronary classification [8], 45 patients were encountered for type A, 3 for type B, and another 3 for type E. One case that did not precisely fit into one of the described categories was classified as Type B1 according the Sauer classification [9]. The preoperative characteristics of the patients at the time of ASO are shown in Table 1.
                    Table 1

                    Preoperative characteristics

                     

                    Patients or Mean

                    % or Range

                    Age at correction (d)

                    10 ± 49.61

                    2-338

                    Female/Male

                    15/37

                     

                    Weight (g)

                    3505 ± 575.04

                    2480-5420

                    Body surface area (qm)

                    0.22 ± 0.03

                    0.13-0.18

                    TGA pathology

                      

                    Simple TGA

                    34

                    65.4

                    TGA with VSD

                    10

                    19.3

                    Taussig-Bing

                    2

                    3.8

                    TGA with CoA

                    2

                    3.8

                    TGA with CoA + VSD

                    4

                    7.6

                    Preoperative cardiopulmonary support

                      

                    Prostaglandin therapy

                    42

                    80.8

                    Duration between Rashkind maneuver to surgery

                    7 ± 42.45

                    1-271

                    Balloon atrial septostomy

                    48

                    92.3

                    Surgery prior Switch

                      

                    Blalock-Hanlon-Operation

                    3

                    5.7

                    Pulmonary artery banding

                    2

                    3.8

                    CoA correction

                    2

                    3.8

                    CoA correction and AAO repair

                    1

                    1.9

                    Complications prior surgery

                      

                    Intracranial hemorrhage

                    1

                    3.8

                    Renal disorder

                    1

                    3.8

                    Chest infection

                    1

                    3.8

                    Mechanical ventilatory support

                    34

                    65.4

                    Vital parameter prior surgery

                      

                    Mean arterial pressure (mmHg)

                    59 ± 10.49

                    37-85

                    Heart rate (beats/min)

                    140 ± 16.98

                    110-183

                    Dimensions of great vessels

                      

                    Mean diameter of the aorta (mm)

                    11 ± 1.56

                    8-15

                    Mean diameter of pulmonary artery (mm)

                    12 ± 1.84

                    10-17

                    Coronary pattern (Yacoub)

                      

                    A/D/E

                    45/3/3

                    86.5/5.8/5.8

                    Coronary pattern (Sauer)

                      

                    B1

                    1

                    1.9

                    TGA: Transposition of the great arteries; VSD: ventricular septal defect; CoA: Coarctation of the aorta;

                    AAO: aortic arch obstruction.

                    Statistics analysis

                    Statistical analysis was performed by using commercial statistic software (Statistica 5.1.®, StatSoft Inc., Tulsa, OK, USA). Descriptive data for continuous variables are presented as mean ± SD, and categoric variables are presented as relatives frequencies. A multivariate analysis was performed by means of a logistic regression model for the endpoint of in-hospital mortality and by means of a Cox proportional hazard model for the endpoints of late mortality. Variables with P values less than 0.05 in univariate analysis were entered into the multivariate models. Freedom from time-related events was calculated using the product-limit method of Kaplan-Meier.

                    Results

                    Intraoperative characteristics

                    A standard ASO was performed in all patients, including a Lecompte maneuver. The techniques for the coronary artery transfer varied depending on the coronary anatomy and included the trap door technique.

                    Surgery was performed in moderate hypothermia (24°C). Myocardial protection was achieved by application of Bretschneider´s crystalloid cardioplegia (Custidiol HTK, Köhler Chemie, Germany). The right atrium was then incised and the cardioplegic solution was aspirated from coronary sinus. After transection of the great vessels, the coronary arteries were excised (in U fashion) and subsequently re-implanted in the neo-aorta. The Lecompte maneuver was performed before anastomosis of the neo-aortic root and distal ascending aorta was completed. The neo-pulmonary trunk was reconstructed with pantaloon-like untreated autologous pericardial patch. Then, the atrial septal defect (or a large foramen ovale) was closed, usually by running suture. Finally, the anastomosis between the distal pulmonary artery and the neo-pulmonary trunk was performed. Reperfusion of the heart and re-warming started after closure of the atrial septal defect.

                    Along with the ASO, 22 concomitant procedures were performed including closure of VSD (n = 15), closure of VSD with repair of CoA (n = 3), re-repair of CoA (n = 2), and pulmonary artery de-banding (n = 2). The mean cardiopulmonary bypass (CPB) time and the mean aortic cross clamp time was 231.5 ± 96.16 minutes (range, 129–838 minutes) and 94 ± 26.18 minutes (range, 58–152 minutes) respectively. The mean body core temperature was 24.5 ± 2.54°C (range, 17–27.5°C). In 34 (66%) patients the chest was left open for a delayed sternal closure. There were 2 (4%) intraoperative deaths which occurred during 1991–1994. All the results are summarized in Table 2.
                    Table 2

                    Intraoperative characteristics

                     

                    Patients or Mean

                    % or Range

                    Additional procedures

                    22

                    42.3

                    VSD closure

                    15

                    28.8

                    VSD closure and CoA

                    3

                    5.8

                    CoA re-repair

                    2

                    3.8

                    Debanding of pulmonary artery

                    2

                    3.8

                    Duration of surgery (min)

                    414 ± 106.56

                    220-865

                    Intraoperative

                      

                    CPB (min)

                    231.5 ± 96.16

                    129-838

                    Ischemic time (min)

                    94 ± 26.18

                    58-152

                    Core temperature (C°)

                    24.5 ± 2.54

                    17-27.5

                    Nitroprusside (μg/kg/min)

                    0.6 ± 0.67

                    0.1-3

                    Open chest after surgery

                    34

                    65.4

                    Death

                    2

                    3.8

                    VSD: ventricular septal defect; CoA: Coarctation of the aorta, CPB: Cardiopulmonary bypass.

                    Postoperative characteristics

                    The postoperative characteristics of patients are shown in Table 3. Within the first 24 hours the left arterial pressure (LAP) was 12 ± 3.88 mmHg (range, 5–21 mmHg) and the mean arterial pressure was 54 ± 7 mmHg (range, 41–70 mmHg). The Levels of serum creatine phosphokinase (S-CPK) and serum creatine phosphokinase-MB (CPK-MB) were 41 ± 307 U/L (range, 41–1463 U/L) and 25.5 ± 21 U/L (range, 7–85 U/L) respectively. In intensive care unit (ICU) the transfusion of red cell and fresh frozen plasma was calculated to 294 ± 163 ml (range, 75–686 ml) and 330 ± 363 ml (range, 50–1310 ml) respectively. The duration of postoperative mechanical ventilation was 6 ± 6 days, (range, 1–28 days) and 11(25%) patients required re-intubated due to respiratory failure. The mean ICU length of stay was 10 ± 10.83 days (range, 5–57 days), and the mean hospital stay was 26 ±16.33 days (range, 14–98 days).
                    Table 3

                    Postperative charactistics

                     

                    Patients or Mean

                    % or Range

                    First 24 hrs

                      

                    LAP (mmHg)

                    12 ± 3.88

                    5-21

                    Mean arterial pressure (mmHg)

                    54 ± 7

                    41-70

                    S-CPK (U/L)

                    41 ± 307

                    41-1463

                    S-CPK-MB (U/L)

                    25.5 ± 21

                    7-85

                    ICU

                      

                    Red cell transfusion (ml)

                    294 ± 163

                    75-686

                    Fresh frozen plasma transfusion (ml)

                    330 ± 363

                    50-1310

                    Duration of mechanical ventilation (d)

                    6 ± 6

                    1-28

                    Re-intubation

                    11

                    25

                    Length of ICU stay (d)

                    10 ± 10.83

                    5-57

                    Length of hospital stay (d)

                    25.5 ± 16.33

                    14-98

                    Early complications

                      

                    Pacemaker implantation

                    1

                    2

                    Myocardial infarction

                    1

                    2

                    Rethoracotomy

                    1

                    2

                    Echocardiography at discharge

                      

                    Vmax pulmonary artery (m/s)

                    1.9 ± 0.63

                    0.9-3.2

                    Vmax aorta ascendens (m/s)

                    1.5 ± 0.29

                    1.2-2.9

                    LVEDD (mm)

                    21 ± 2.3

                    17-25.7

                    LVESD (mm)

                    14 ± 3

                    8-20

                    FS (%)

                    35 ± 7

                    22-46

                    LAP: left atrial pressure; S-CPK: serum creatine phosphokinase; S-CPK-MB: creatine.

                    Phosphokinase-MB; ICU: Intensive care unit; Vmax: peak velocity; LVEDD: left ventricular end diastolic dimension; LVESD: left ventricular end-systolic dimension: FS: Fractional shortening.

                    Early complication occurred in 4 patients. In 1 (2%) a pacemaker was implanted due to complete AV block, 1 (2%) had a myocardial infarction, and 1 (2%) had two re-thoracotomies. This patient had a surgical bleeding on the first postoperative day which was successfully treated and on the 22nd postoperative day right atrial thrombi were detected on echocardiography, presumably due to a central venous catheter, which required surgical removal.

                    The postoperative echocardiography at time of discharge was performed in all patients and is summarized in Table 3. The peak velocity (Vmax) in the pulmonary artery and the aorta were 1.9 ± 0.63 m/s (range, 0.9-3.2 m/s) and 1.5 ± 0.29 m/s (range, 1.2-2.9 m/s) respectively (data diameters of the neoaortic root indexed to BSA were not available) . The fractional shortening of the left ventricle was normal in all patients (35% ± 7%; range, 22% to 46%). The measurements of LV end-diastolic and end-systolic diameters were 21 ± 2.3 mm (range, 17 to 26 mm) and 14 ± 3 mm (range, 8 to 20 mm) respectively which were within normal range.

                    Outcome

                    All over (1991–1999) mortality rate was 15.4% (n = 8) and was observed in the early postoperative period only till 1994. Out of these patients the majority (87.5%) died in the first 30 days after ASO.

                    Five patients died within first 24 hours postoperatively. In two of them weaning from CPB was failed due to irreversible left heart failure and one patient had an acute refractory right heart failure due to suspected malperfusion of the right coronary artery. This patient had a type E coronary pattern according Yacoub’s classification. The remaining 2 patients underwent an uncomplicated surgery but died in ICU due to refractory left heart failure.

                    Two deaths occurred on second and fifth postoperative day on ICU due to multi organ failure related to a left heart failure. The last patient died on the 50th postoperative day due to poor hemodynamic conditions, multiple resuscitations and the cause of death was left heart failure. That patient did not receive a control angiography, because there was so far no indication for that. The initial course went uneventful. There were no signs of myocardial infarction and the lab values did not show a myocardial ischemia. ECG and echocardiography were fine till day 20 postoperatively. Then the patient detoriated with signs of left heart failure, which resulted in a multiorgan failure (Table 4). None of our patients received a revision of the coronary arteries in the early postoperative phase.
                    Table 4

                    Deaths

                    No.

                    Age at surgery (d)

                    Accompanied diagnosis

                    Concomitant procedure

                    Cause

                    1

                    16

                    VSD

                    VSD closure

                    Right heart failure

                    2

                    41

                    VSD, CoA

                    VSD closure, CoA repair

                    Left heart failure

                    3

                    5

                    VSD

                    VSD closure

                    Left heart failure

                    4

                    20

                    VSD, CoA

                    VSD closure, CoA repair

                    Left heart failure

                    5

                    144

                    Taussig-Bing

                    -

                    Left heart failure

                    6

                    338 [preterm, 31 w]

                    Taussig-Bing, bronchopulmonary dysplasia

                    Neoaortic root enlargement with a pulmonary artery patch

                    Left heart failure, Multi organ failure

                    7

                    7 [preterm, 36 w]

                    -

                    -

                    Left heart failure

                    8

                    18 [preterm, 35 w]

                    respiratory distress syndrome, diabetic fetopathy

                    -

                    Left heart failure, Multi organ failure

                    VSD: ventricular septal defect; CoA: Coarctation of the aorta.

                    Late complications were observed in 7 patients and included convulsions in 1, myocardial malperfusion in 1, arrhythmia in 2, sternal wound infection in 1, and in 2 patients a chylothorax was observed.

                    The survivors were seen by the referring pediatric cardiologist at regular intervals or in our institution by the pediatric cardiologist. The follow-up time ranged from 1–10 years (mean 5 years, cumulative 260 patient-years) postoperatively. In majority of patients (93%), functional NYHA class I, with normal LV-function with no symptoms referable to the cardiovascular system was seen. There were no late deaths. Late re-operations were necessary in 9 (20%) patients and included a pulmonary artery patch enlargement due to supravalvular stenosis (n = 3), coronary revascularisation due to coronary stenosis in a coronary anatomy type E and aortic valve replacement due to neoaortic valve regurgitation (n = 2), and patch plasty of a pulmonary vein due to obstruction (n = 1). Two patients required pacemaker implantation due to complete AV block and one patient due to sick sinus syndrome. The dilatation of neoaortic root was not observed in any of the patients during the follow up (Table 5).
                    Table 5

                    Outcome

                     

                    Patients

                    %

                    Mortality all over (1991–1999)

                    8

                    15.4

                    Late complications

                      

                    Convulsions

                    1

                    2.2

                    Myocardial malperfusion

                    1

                    2.2

                    Arrhythmia

                    2

                    4.4

                    Sternal wound infection

                    1

                    2.2

                    Chylothorax

                    2

                    4.4

                    Follow up n = 44

                      

                    NYHA I

                    41

                    93.2

                    NYHA II

                    0

                     

                    NYHA III

                    3

                    6.8

                    NYHA IV

                    0

                     

                    Mortality

                    0

                     

                    Reoperations

                      

                    Dilatation of neoaortic root

                    0

                     

                    Pulmonary artery patch enlargement

                    3

                    6.6

                    Coronary revascularisation and aortic valve replacement

                    2

                    4.4

                    Patch plasty of a pulmonary vein

                    1

                    2.2

                    Pacemaker implantation

                    3

                    6.6

                    NYHA: New York Heart Association.

                    Risk factors for mortality

                    A linear regression analysis was performed to determine possible associations of anatomic and physiologic parameters with the mortality. The predictors’ analysis for poor operative survival was: preterm birth (p = 0.0008), long duration between cardiac catheterization and surgery (p = 0.006), older age at surgery (p = 0.004), necessity of associated procedures (p = 0.004), redo surgery (p = 0.04), prolonged ischemia (p = 0.0002), and no treatment with prostaglandin prior surgery (p = 0.002) (Table 6).
                    Table 6

                    Risk factors for mortality

                     

                    p-value

                    Preterm birth

                    0.0008

                    Long duration between cardiac catheterization and surgery

                    0.006

                    Older age at surgery

                    0.004

                    Necessity of associated procedures

                    0.004

                    Redo surgery

                    0.04

                    Prolonged ischemia time

                    0.0002

                    No treatment with prostaglandin prior surgery

                    0.002

                    Discussion

                    The goal of this study was to identify predictors for mortality and to review adverse events after ASO for TGA (coronary stenoses, distortion of the pulmonary arteries, dilatation of the neoaortic root, and aortic regurgitation). This study confirms that ASO can be performed with acceptable early and late outcome in patients with TGA even in a small centre after a learning process and modifications of the perioperative setting.

                    The possible deterioration of neoaortic valve function with a dilatation of neoaortic root [7] and presence of coronary stenosis [2] is one of the major concerns of ASO. In the present study, the need of surgical re-intervention of coronary stenosis in the follow up was low (4.5%). Similar results have been described by Bonhoeffer et al. for late stenoses after ASO [10]. In our patient population, 23 of the survivors who have been evaluated by angiography, 2 were found to have complete occlusion of the right coronary artery and 1 had left coronary artery occlusion. The patients with the affected right coronary artery had Yacoub’s type E coronary pattern and showed clinical symptoms, which were associated with myocardial ischemia in the year five and seven postoperatively. They were treated surgically with an internal mammary artery grafting, which is one of the possible approaches to manage coronary stenoses after ASO [11]. Although in both patients a good result were achieved with this approach, we recommend a regular follow up by angiography in view of the lack of long-term follow up studies about internal mammary grafting in children. The patient with occluded left coronary artery coronary (Yacoub’s type A coronary pattern) was treated conservatively, as the routine angiography revealed a good collateralisation and the patient had no clinical signs of a myocardial ischemia. In the latest follow up, this patient was in functional NYHA class I with no symptoms referable to the cardiovascular system.

                    Several investigators have noted that a deterioration of neoaortic valve function and dilatation of neoaortic root were frequently observed in patients after ASO [12, 13]. In the present series two patients developed severe aortic regurgitation (AR) and required an aortic valve replacement at 6 and 8 years after ASO. One of them had a VSD which was also closed during the ASO procedure. Interestingly, both of them had Yacoub’s type E coronary pattern and received an internal mammary artery grafting as well, but there is no explanation for the combined occurrence. It was reported that the risk of moderate or severe AR with a significant left ventricular dilatation followed by an aortic valve replacement is low after ASO and the results in this study are similar to other studies [7, 13]. Risk factors for AR following ASO included prior history of PA band, Taussig-Bing hearts, and development neo-aortic root enlargement [7]. Surprisingly, in our series the patients with AR who required aortic valve replacement had none of these risk factors. Moreover, we did not observe a neo-aortic root enlargement at all in the follow-up and this is in contrast to other studies which state that that is one of the major concerns of ASO [7]. This could be because of the small size of our series. Although several factors for neo-aortic root enlargement are described, these are speculative and require further investigations. The incidence of pacemaker implantation due to the complete AV block in two and the sick sinus syndrome in one was not different from that in another study [14].

                    The postoperative mortality and morbidity in this series was higher compared to the recently reported series. We observed an all over mortality rate of 15% (n = 8). The mortality rate seems to be high compared with other published series; however, the mortality was seen only during first 4 years of the observation period which was early nineties. Reasons for that improved outcome after 1994 could be that the ICU treatment made a progress and also the learning curve regarding the surgery has improved in a short time. Moreover, more patients were presented in a better clinical condition in the second time interval.

                    Seven patients died in the early postoperative period (30 days) and five of them within first 24 hrs. Cause of death was dominated mostly by postoperative refractory left heart failure. In our statistical analysis preterm birth, long duration between cardiac catheterization and surgery, older age at surgery, necessity of associated procedures, redo- surgery, prolonged ischemia, and no treatment with prostaglandin prior surgery were associated with mortality and were partly in line with other published series [6, 15]. Maybe it is possible that some of the patients could be supported by an extracorporeal membrane oxygenation (ECMO) in the initial early postoperative phase; however this kind of circulatory support was first introduced in our department in the late nineties.

                    Interestingly, in our series the presence of a complex coronary anatomy including intramural course was not a significant risk factor for mortality and corroborates with the study of Blume et al. [16]. The results of this study show that the impact of well described risk factors influencing the mortality diminishes with surgical experience. The experience after 1994 has further improved early survival after ASO and may also result in less mid-term complications. After 1994, no postoperative deaths were observed. This result is gratifying and compares favourably with other big series [3, 15].

                    We acknowledge that this study has several limitations being an observational assessment of outcomes. The patients were not randomly assigned to various therapies, and comparison between inherently dissimilar groups is problematic. Data regarding follow-up and re-interventions were incomplete in some patients; however continued study will be necessary for a truly long-term follow-up.

                    Conclusion

                    In conclusion ASO remains the procedure of choice for TGA with acceptable early and late outcome in terms of overall survival and freedom of reoperation. The need for close long-term monitoring in these patients is import to detect any structural changes or changes of hemodynamic which could affect the postoperative result.

                    Declarations

                    Authors’ Affiliations

                    (1)
                    Department of Thoracic and Cardiovascular Surgery, University of Göttingen
                    (2)
                    Department of Anaesthesiology, Emergency and Intensive Care Medicine, University of Göttingen
                    (3)
                    Department of Pediatric Cardiology and Pediatric Intensive Care Medicine, University of Göttingen
                    (4)
                    Presented in part at the 8th International Conference Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion June 13–16, 2012

                    References

                    1. Jatene AD, Fontes VF, Paulista PP, de Souza LC, Neger F, Galantier M, Souza JE: Successful anatomic correction of transposition of the great vessels. A preliminary report. Arq Bras Cardiol. 1975,28(4):461–4.
                    2. Kirklin J, Blackstone E, Tchervenkov C, Castaneda A: For the Congenital Heart Surgeons Society. Clinical outcomes after the arterial switch operation for transposition: patient, support, procedural and risk factors. Circulation. 1992, 86:1501–15.PubMedView Article
                    3. Daebritz SH, Nollert G, Sachveh JS, Engelhardt W, Von Bernuth G, Messmer BJ: Anatomical risk factors for mortality and cardiac morbidity after arterial switch operation. Ann Thorac Surg. 2000, 69:1880–86.PubMedView Article
                    4. Brown JW, Park HJ, Turrentine MW: Arterial switch operation: factors impacting survival in the current era. Ann Thorac Surg. 2001, 71:1978–84.PubMedView Article
                    5. Haas F, Wottke M, Poppert H, Meisner H: Long-term survival and functional follow-up in patients after arterial switch operation. Ann Thorac Surg. 1999, 68:1692–97.PubMedView Article
                    6. Wernovsky G, Mayer JE, Jonas RA, Hanley FL, Blackstone EH, Kirklin JW, Castaneda AR: Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries. J Thorac Cardiovasc Surg. 1995, 109:289–302.PubMedView Article
                    7. McMahon CJ, Ravekes WJ, Smith EO, Denfield SW, Pignatelli RH, Altman CA, Ayres NA: Risk factors for neo-aortic root enlargement and aortic regurgitation following arterial switch operation. Pediatr Cardiol. 2004, 25:329–35.PubMedView Article
                    8. Yacoub MH, Radley-Smith R: Anatomy of the coronary arteries in transposition of the great arteries and methods for their transfer in anatomical correction. Thorax. 1978,33(4):418–24.PubMedView Article
                    9. Sauer U, Gittenberger-de-Groot AC, Peters D, Bühlmeyer K: Cineangiography of the coronary arteries in transposition of the great arteries. Pediatr Cardiol 1983,4(4):25–42.
                    10. Bonhoeffer P, Bonnet D, Piéchaud JF, Stümper O, Aggoun Y, Villain E, Kachaner J, Sidi D: Coronary artery obstruction after the arterial switch operation for transposition of the great arteries in newborns. J Am Coll Cardiol. 1997,29(1):202–6.PubMedView Article
                    11. Mavroudis C, Backer CL, Duffy CE, Pahl E, Wax DF: Pediatric coronary artery bypass for Kawasaki congenital, post arterial switch, and iatrogenic lesions. Ann Thorac Surg. 1999,68(2):506–12.PubMedView Article
                    12. Schwartz ML, Gauvreau K, del Nido P, Mayer JE, Colan SD: Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 2004, 110:128–32.View Article
                    13. Vandekerckhove KD, Blom NA, Lalezari S, Koolbergen DR, Rijlaarsdam ME, Hazekamp MG: Long-term follow-up of arterial switch operation with an emphasis on function and dimensions of left ventricle and aorta. Eur J Cardiothorac Surg. 2009,35(4):582–7.PubMedView Article
                    14. Williams WG, McCrindle BW, Ashburn DA, Jonas RA, Mavroudis C, Blackstone EH: Congenital Heart Surgeon's Society. Outcomes of 829 neonates with complete transposition of the great arteries 12–17 years after repair. Eur J Cardiothorac Surg. 2003,24(1):1–9.PubMedView Article
                    15. Dibardino DJ, Allison AE, Vaughn WK, McKenzie ED, Fraser CD: Current expectations for newborns undergoing the arterial switch operation. Ann Surg. 2004,239(5):588–96.PubMedView Article
                    16. Blume ED, Altmann K, Mayer JE, Colan SD, Gauvreau K, Geva T: Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol 1999,33(6):1702–9.PubMedView Article

                    Copyright

                    © Popov et al.; licensee BioMed Central Ltd. 2012

                    This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.